These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31956135)

  • 1. Recovered Left Ventricular Ejection Fraction and Its Prognostic Impacts in Hospitalized Heart Failure Patients with Reduced Ejection Fraction.
    Abe S; Yoshihisa A; Ichijo Y; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Int Heart J; 2020 Mar; 61(2):281-288. PubMed ID: 31956135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes.
    Basuray A; French B; Ky B; Vorovich E; Olt C; Sweitzer NK; Cappola TP; Fang JC
    Circulation; 2014 Jun; 129(23):2380-7. PubMed ID: 24799515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with recovered ejection fraction (HFrecEF): A new entity with improved cardiac outcome.
    Zeller J; Hubauer U; Schober A; Schober A; Keyser A; Fredersdorf S; Uecer E; Maier LS; Jungbauer C
    Pacing Clin Electrophysiol; 2021 Dec; 44(12):2015-2023. PubMed ID: 34687476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
    Vivo RP; Krim SR; Krim NR; Zhao X; Hernandez AF; Peterson ED; Piña IL; Bhatt DL; Schwamm LH; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):167-75. PubMed ID: 22414939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Impact of the Renal Resistive Index on Future Cardiovascular Events in Hospitalized Atherosclerotic Cardiovascular Patients According to Left Ventricular Ejection Fraction　- The Jichi Vascular Hemodynamics in Hospitalized Cardiovascular Patients (J-VAS) Study.
    Kotruchin P; Hoshide S; Ueno H; Shimizu H; Komori T; Kario K
    Circ J; 2020 Aug; 84(9):1544-1551. PubMed ID: 32741880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcomes of Atrial Fibrillation in Patients With Reduced Versus Preserved Left Ventricular Ejection Fraction.
    Benjamin MM; Chaddha A; Sampene E; Field ME; Rahko PS
    Am J Cardiol; 2016 Dec; 118(12):1831-1835. PubMed ID: 28029361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with recovered ejection fraction: a distinct clinical entity.
    Punnoose LR; Givertz MM; Lewis EF; Pratibhu P; Stevenson LW; Desai AS
    J Card Fail; 2011 Jul; 17(7):527-32. PubMed ID: 21703523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.